Ionis Pharmaceuticals IONS Valuation Allowances And Reserves Period Increase Decrease
Valuation Allowances And Reserves Period Increase Decrease at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's valuation allowances and reserves period increase decrease.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's valuation allowances and reserves period increase decrease?
- Ionis Pharmaceuticals (IONS) reported valuation allowances and reserves period increase decrease of $26.75M in Q4 2025.
- What does valuation allowances and reserves period increase decrease mean?
- The change in the reserve set aside for tax assets that may not be usable.
- How do you interpret valuation allowances and reserves period increase decrease?
- A decrease in the allowance often signals improved future profitability expectations, while an increase suggests uncertainty regarding tax asset realization.
- How does valuation allowances and reserves period increase decrease compare across companies?
- High volatility is common in pre-revenue or early-stage commercial companies.